GLP1R and type 2 diabetes mellitus: As a result of this exploratory study and literature search, and based on the observed down-regulation of collagen peptides in the urinary peptidome, we may thus predict for the first time the down-regulation of MMP proteases following treatment with GLP-1R agonists in T2DM patients.